SCHEMBL2983577

SCHEMBL2983577

BrCc1cc(I)ccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21610450 0.79 — —
SCHEMBL4864193 0.77 — —
SCHEMBL4265097 0.77 — —
SCHEMBL14086544 0.77 — —
SCHEMBL17911800 0.76 TRPA1 (0.36) —
SCHEMBL15160638 0.76 HDAC8 (0.39) —
SCHEMBL29898951 0.74 — —
SCHEMBL2299751 0.74 — —
SCHEMBL20197212 0.74 KDM4E (0.53) —
SCHEMBL20197181 0.74 HDAC8 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029543-B1 SUBSTITUTED 3-CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS WYETH LLC (US) 2015-11-18 — — EP disclosed
US-7781591-B2 Substituted 3-cyanopyridines as protein kinase inhibitors WYETH LLC (US) 2010-08-24 — — US disclosed
EP-2029543-A2 SUBSTITUTED 3-CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS Wyeth (US) 2009-03-04 — — EP disclosed
US-7414036-B2 Compounds useful as A3 adenosine receptor agonists MUSCAGEN LIMITED (GB) 2008-08-19 — — US disclosed
US-7414036-B2 Compounds useful as A3 adenosine receptor agonists MUSCAGEN LIMITED (GB) 2008-08-19 — — US disclosed
US-7414036-B2 Compounds useful as A3 adenosine receptor agonists MUSCAGEN LIMITED (GB) 2008-08-19 — — US disclosed
WO-2007146376-A2 SUBSTITUTED 3-CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS WYETH (US) 2007-12-21 — — WO disclosed
US-20070287708-A1 Substituted 3-cyanopyridines as protein kinase inhibitors WYETH LLC 2007-12-13 — — US disclosed
US-20050101551-A1 Compounds useful as A3 adenosine receptor agonists MUSCAGEN LIMITED (GB) 2005-05-12 — — US disclosed
WO-2005012323-A2 COMPOUNDS USEFUL AS A3 ADENOSINE RECEPTOR AGONISTS TRIGEN LIMITED (GB) 2005-02-10 — — WO disclosed
EP-1469864-A1 COMPOUNDS USEFUL AS A-3 ADENOSINE RECEPTOR AGONISTS MUSCAGEN LIMITED (GB) 2004-10-27 — — EP disclosed
WO-2003061670-A1 COMPOUNDS USEFUL AS A3 ADENOSINE RECEPTOR AGONISTS MUSCAGEN LIMITED (GB) 2003-07-31 — — WO disclosed
Send feedback